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and Ta-Chau Changbc
A binary molecule can self-assemble to form ﬂuorescent organic nanoparticles (FONs) based on the
Aggregation-Induced Emission Enhancement (AIEE) property and subsequently, presents an eﬃcient
ﬂuorescence resonance energy transfer (FRET) to generate singlet oxygen under linear and nonlinear
light sources. Biologically, this FON-photosensitizer is much more phototoxic to cancer cells than to
normal cells without signiﬁcant dark toxicity. Eventually, a new approach, called FON FRET-PDT or AIEE
FRET-PDT, to promote the PDT eﬀect is expected.Introduction
Fluorescent organic nanoparticles (FONs), which have recently
received a considerable amount of attention, are expected to
function in a wide variety of applications because the synthetic
approaches are exible for these organic compounds.1,2
Notably, studies on the application of FONs in cancer cell
detection and diagnosis are lacking. In previous studies, we
developed FON models for anionic and cationic organic dyes by
using their aggregation-induced emission enhancement (AIEE)
properties, and described their application in cellular staining.3
We then developed a vacuole model using FONs to elucidate the
formation of uorescent bright spots that are thought to form
in the lysosomes of cancer cells and have been identied for
specic cancer cell recognition.4 In this study, we attempted to
establish a concept that takes advantage of FONs in photody-
namic therapy (PDT) drug potency because in most cases, the
aggregation of the photosensitizer usually decreases the
quantum yields of uorescence and singlet oxygen generation,5
especially in nanocarrier incorporated-photosensitizer systems.
This phenomenon will result in an incomplete release or
signicant reduction of the photodynamic activity by self-pho-
toquenching.6 Therefore, once the molecular aggregation
behavior was found, whatever has been characterized in
aqueous or nonaqueous medium should be considered in the
cell and its phototoxicity should also be evaluated.7g, National Chung Hsing University, 250
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50–2357Recently, the disadvantage of PDT caused by aggregation of
the photosensitizer has been diminished by the FRET-PDT
binary systemmodel by the use of quantum dots8 or two-photon
absorbing chromophores9 as a FRET donor to indirectly activate
the acceptor photosensitizer. These binary systems can not only
decrease the aggregation tendency of photosensitizers but are
also able to support a new optical window for cancer imaging
and therapies.10 Here, combining the FRET-PDT and FON
models, we expect that the emission of the FRET donor
increases due to its AIEE property while the aggregation of the
FRET acceptor (photosensitizer) decreases.
That is, once the FRET-PDT system forms a uorescent
nanoparticle based on AIEE behavior, a new approach (called
FON FRET-PDT or AIEE FRET-PDT) to promote the PDT eﬀect
is expected. In this manuscript, a binary conjugate was con-
structed with a FRET donor (BMVC, 3,6-bis-(1-methyl-4-vinyl-
pyridinium)-carbazole diiodide) and an FRET acceptor
(porphyrin or metalloporphyrin), as shown in Scheme 1. The
former acts as a linear and nonlinear light capturing antenna,
factor of AIEE, FRET donor and supports the specic recog-
nition of these binary conjugates for cancer cells; the latter
acts as a FRET acceptor and the photoactive center of the
binary complex to generate singlet oxygen. The strategy is: the
binary conjugate can self-assemble to form FONs which result
from the AIEE of the BMVC moiety but not the porphyrin
moiety. The AIEE from the aggregated BMVC induced eﬃ-
cient FRET to the non-aggregated porphyrin, and then to
eﬃciently generate singlet oxygen. Furthermore, the FRET
eﬃciency is a critical factor that depends on the overlap
between the emission energy of BMVC and the excitation
cross-section of porphyrin. To t the BMVC emission and
improve the FRET eﬃciency of the binary molecule, we
consider metalloporphyrin as the acceptor and evaluate the
PDT eﬃciency.This journal is ª The Royal Society of Chemistry 2013
Scheme 1 The structure of binary compound Zn-2BPs (Ps: porphyrin) and the
FRET schematic diagram between the emission spectrum and porphyrin or
metalloporphyrin.
Paper Journal of Materials Chemistry BMolecule design
A previous study has shown that substituting two BMVC mole-
cules at the 5- and10-positionsof tetra-phenylporphyrin (product
named 2BPs, Scheme 1) presented the optimal PDT eﬀect basedFig. 1 (a) The UV-vis absorption spectra and (b) relative singlet oxygen yields
(1DO2) of metalloporphyrin derivatives under white light (400–700 nm). TMPP:
metallotetraphenyl-porphyrins.
This journal is ª The Royal Society of Chemistry 2013on the biological evaluation from their structure–activity rela-
tionship.11 As we mentioned above, to improve the FRET ratio of
the 2BPs, we consider metalloporphyrin as the acceptor. It is
known that the presence and nature of the central metal ion,
which is bound by a number of photosensitizers, strongly inu-
ence the photophysical properties of the photosensitizer.12 To
date however, for porphyrin derivatives, there has been no
consistent observation as to the potential success of metallated
photosensitizers. Therefore, before synthesizing the binary
system, we prepared various tetraphenyl-metalloporphyrins and
determined themost suitable acceptorbasedon the criteriaof the
absorption energy of the Q-bands and singlet oxygen yields
(Fig. 1). Furthermore, for physiological consideration, zinc is
more suitable than cadmium. This is why Zn-2BPs was prepared
and eventually, more eﬃcient FRET is expected because of either
the linear or nonlinear optical properties.Experimental section
1 Materials
The general chemicals employed in this studywere of the highest
grade available and were obtained from Acros Organic Co.,
Merck Ltd, or Aldrich Chemical Co. and used without further
purication. All of the solvents were of spectrometric grade.2 Apparatus
The absorption spectra were generated using a Thermo Genesys
6 UV-visible spectrophotometer, and the uorescence spectra
were recorded using a HORIBA JOBIN-YVON Fluoromas-4 spec-
trouorometer with a 1 nm band-pass and a 1 cm cell length at
room temperature. Transmission electron microscopy (TEM)
was performed on a Zeiss EM 902A operated at 80 kV. A mixed
solution (amixed solvent of THF and deionized water, 50/50, v/v)
that contained the compound was deposited onto a carbon-
coated copper grid. Nanoparticle sizes and sizing partition
curves were directly measured using NanoSight LM20 and NTA
2.0 Analytical Soware in the same solution. The cellular uo-
rescence images and dual staining uorescence images were
taken using a Leica AF6000 uorescence microscope with a
DFC310 FX Digital color camera and the l scanning was taken
using the Leica TCS SP5 confocal uorescence microscope. The
excitation source was a 488 nm Ar laser for the compounds.
Fluorescence photographs were taken through the related
wavelength ranges using photomultiplier tubes (PMT). The light
source used to measure the singlet oxygen yield and PDT cell
death was the Xenon Light Source LAX-Cute (Asahi Spectra). For
two-photon excitation, we used a Ti-sapphire laser (Mira-900F,
Coherent, USA) at 900 nmwavelength, which was directed into a
laser scanning microscope (FV300 and IX-71, Olympus, Japan)
and focused onto the sample using a 60 (N.A. ¼ 1.2) water
immersion objective (UPLSAPO 60XW, Olympus, Japan).3 Cell culture conditions and compound incubation
The human embryonal lung MRC-5 normal broblast cells and
HeLa human cervical cancer cells were maintained in Modied
Eagle's Medium (MEM) containing non-essential amino acids,J. Mater. Chem. B, 2013, 1, 2350–2357 | 2351
Journal of Materials Chemistry B PaperEarle's salts, L-glutamine, 1 mM sodium bicarbonate, 1 mM
sodium pyruvate, 1% (penicillin + streptomycin) and 10% fetal
bovine serum (FBS); the human lung adenocarcinoma cell line
CL1-0 was maintained in RPMI-1640 medium containing 1%
(penicillin + streptomycin), sodium bicarbonate (2.0 g L1) and
10% FBS. The cells were cultured at 37 C in a humid atmo-
sphere with 95% air and 5% CO2. Before the observation of
cellular localization, the cells were seeded onto coverslips and
incubated for 24 h. The next day, cells were incubated with
diﬀerent concentrations of compounds for 12 h, for which the
DMSO stock solutions were diluted in serum-free medium
before use (1/100 v/v).4 Measurement
The light source formeasurement of the singlet oxygen yield and
PDT cell death was a white light (a 20 W xenon lamp that passes
through a 400–700 nm mirror module). Before the light was
output from the optional light guide and collimator lens, the
light passed through a 470 nm band pass (bp) lter (the light
power was 30 mW cm2 on the dish surface). The singlet oxygen
quantum yields from compounds that were in an organic solvent
or amixed solution (THF/deionized water, FON conditions) were
determined by a photo-steady-state method using 1,3-dipheny-
lisobenzofuran as the scavenger. The critical micelle concen-
tration was measured by monitoring the ratios of emission
intensities aer excitation at 470 nm and Soret band (I470/Isoret)
andobserving thebreakpoints in thetting curves.Dual staining
of the tracker and compound: the cells were rst incubated with
the compound for 12 hours, which was followed by incubation
with 5 mMorganelle probes (MitoTracker green FM for 20min at
37 C, LysoTracker green DND-99 for 30 min at 37 C), and then
washed with PBS before observation. The excitation source was a
green light cube, in which the light passed through a 530/20 nm
bplter and the emissionwas collected througha590nm lplter
(red emission of compound) and a blue light cube, inwhich light
passed through a 480/10 nm bp lter and the emission was
collected through a 510 nm lp lter to collect green emission of
probes. Once the denite yellow color image was obtained, we
said that the compound was co-localized with the probes. PDT-
induced phototoxicity was determined using propidium iodide
under a uorescence microscope (excitation/emission maxima
535/617 nm) and conrmed by Trypan blue exclusion and
staining assay. For two-photon excitation-PDT experiment, the
cells were plated on a m-slide (80826, ibidi GmbH, Germany) and
were incubated with or without 5 mM of Zn-2BPs for ve hours.
Prior to the experiment, the cells were washed twice with phos-
phate buﬀered saline (PBS), and then relled with freshmedium
with 0.01 mg mL1 propidium iodide (PI, P3566, Invitrogen,
USA), which was used to detect dead cells. The laser exposure
time was 2 ms per pixel. The uorescence from Zn-2BPs and
propidium iodide was detected by the same objective through
epi-detection, passing through a 685 nm short-pass dichroic
mirror (685SPXR, Chroma, USA) and a 694 nm short-pass lter
(FF01-694/SP, Semrock, USA), detected using a PMT (R3896,
Hamamatsu, Japan). In the image/video the uorescence was
pseudo-colored in yellow.2352 | J. Mater. Chem. B, 2013, 1, 2350–23575 Synthesis of the binary conjugates
Scheme 2 shows the synthesis of two binary conjugates. The
detailed synthesis procedures for 2-BPs and compound 3 have
been described previously [ref. 11]. The compound zinc(II) o-
5,10-bis(4-(3,6-bis-(-2-(1-methylpyridium-4-yl)vinyl)-9H-carbazol-
9-yl-butoxyl)phenyl)-15,20-bis(4-methoxylphenyl)porphyrin
iodine (Zn-2BPs) is prepared as follows. A solution of compound
3 (0.2 mmol) in 70 mL of dichloromethane was treated with
30 mL of a saturated solution of zinc(II) acetate in methanol.
The mixture was stirred overnight at room temperature. Aer
that, the solution was treated with water (200 mL) and the
organic phase was extracted with three portions of dichloro-
methane (50 mL each). The solvents were evaporated under
reduced pressure and compound 4 was collected with a high
yield from compound 3. Data for compound 4: 1H-NMR (400 Hz,
DMSO, d): d (ppm) ¼ 8.764 (d, J ¼ 4.4 Hz, 4H), 8.744 (d, J ¼ 4.4
Hz, 4H), 8.544 (d, J ¼ 2 Hz, 4H), 8.474 (d, J ¼ 4 Hz, 8H; pyridine
H), 8.052 (d, J ¼ 8 Hz, 4H; Ar H), 8.007 (d, J ¼ 8 Hz, 4H; Ar H),
7.869 (dd, J¼ 2 Hz, J¼ 8 Hz, 4H), 7.802 (d, J¼ 8.8 Hz, 4H), 7.756
(d, J ¼ 16.4 Hz, 4H; vinyl H), 7.542 (d, J ¼ 4.8 Hz, 8H; pyridine
H), 7.326 (d, J ¼ 8 Hz, 4H; Ar H), 7.280 (d, J ¼ 16.8 Hz, 4H; vinyl
H), 7.249 (d, J¼ 8.8 Hz, 4H; Ar H), 4.608 (t, J¼ 6.8 Hz, J¼ 6.8 Hz,
4H), 4.227 (t, J ¼ 6.8 Hz, J ¼ 6.8 Hz, 4H), 4.014 (s, 6H; OCH3H),
2.104 (m, 4H), 1.914 (m, 4H). HRMS (ESI,m/z): [M + H]+ 1625.24;
found, 1623.0; anal. calcd% for C106H82N10O4Zn: C, 78.34; H,
5.09; N, 8.62. 4$(H2O + CH3COOH): C108H88N10O7: C, 76.16; H,
5.21; N, 8.22. Found, C, 76.03; H, 5.28; N, 8.20%. Aer reuxing
compound 4 with excess CH3I in THF, the nal products of Zn-
2BPs were collected as orange-purple powders that were
recrystallized twice from acetone. Data for Zn-2BPs: 1H-NMR
(400 Hz, DMSO, d): d (ppm) ¼ 8.819 (d, J ¼ 4 Hz, 4H), 8.794 (d, J
¼ 4 Hz, 4H), 8.781 (d, J ¼ 4.4 Hz, 8H; pyridine H), 8.682 (d, J ¼ 2
Hz, 4H), 8.261 (d, J ¼ 16 Hz, 4H), 8.221 (d, J ¼ 5.2 Hz, 8H;
pyridine H), 8.063 (d, J¼ 8 Hz, 4H), 8.043 (d, J¼ 8 Hz, 4H), 8.033
(d, J¼ 8.8 Hz, 4H; Ar H), 7.967 (d, J¼ 8.8 Hz, 4H; Ar H), 7.596 (d,
J¼ 16 Hz, 4H; vinyl H), 7.346 (d, J¼ 8.4 Hz, 4H; Ar H), 7.315 (d, J
¼ 8.4 Hz, 4H; Ar H), 4.707 (t, J¼ 6.4 Hz, J¼ 6.4 Hz, 4H), 4.295 (t,
J ¼ 6.4 Hz, J ¼ 6.4 Hz, 4H), 4.228 (s, 12H, CH3I), 4.032 (s, 6H;
OCH3 H), 2.160 (m, 4H), 1.973 (m, 4H). HRMS (ESI, m/z): [M +
H]+ 1670.34 (exclude I); found, 1665.27; anal. calcd % for
C110H94I4N10O4Zn: C, 60.25; H, 4.32; N, 6.39. Zn-2BPs$3H2O:
C110H110I4N10O4Zn: C, 58.80; H, 4.49; N, 6.23. Found, C, 58.19;
H, 4.51; N, 6.18%.Results and discussion
1 Basic photophysical properties and FRET investigation
Fig. 2(a) presents the absorption (435 nm, Soret band; 564, 605
nm Q-band) and emission (613, 665 nm) spectra of the Zn-2BPs
product in a DMSO solution. Compared to 2-BPs, compound
Zn-2BPs showed a red-shi in the absorption Soret band, while
a blue-shi in emission with lower intensity. No emission signal
from BMVC was observed under these conditions. However, the
evidence of FRET was supported from the experimental results
shown in Fig. 2(b). Both the plots of excited wavelength-
dependent emission intensities at 613 nm (a plot of emissionThis journal is ª The Royal Society of Chemistry 2013
Scheme 2 Synthesis procedure for the binary conjugates: 2BPs and Zn-2BPs.
Fig. 2 (a) The extinction representation of the absorption spectra of BMVC, Zn-
Ps, 2BPs and Zn-2BPs. The inset shows the emission curves of 2BPs and Zn-2BPs.
(b) The ﬂuorescence excitation spectrum of 1 mM Zn-2BPs (green line) and the
plot of excited wavelength-dependent emission intensities at 613 nm from
excitation at 360 to 600 nm.
Paper Journal of Materials Chemistry Bmaximum values against excited wavelength every 10 nm
ranging from 360 to 600 nm, blue line) as well as the uores-
cence excitation spectrum (green line, recording the emission
intensity at 613 nm wavelength) of Zn-2BPs are similar to their
absorption spectrum pattern shown in Fig. 2(a). The experi-
mental results suggest that the emission of the metal-
loporphyrin part in Zn-2BPs can be induced by excitation at
450–500 nm, which corresponds to the absorption region ofThis journal is ª The Royal Society of Chemistry 2013BMVC and the window of transparency for porphyrin and
metalloporphyrin derivatives.2 Investigation of the aggregation-induced emission
enhancement (AIEE) and evolution of the uorescent organic
nanoparticles (FONs)
The AIEE phenomena were conveniently demonstrated by
examining the emission spectra of the compound in various
ratios of H2O–THF (tetrahydrofuran) solvents.1,2 Fig. 3(a) reveals
that the uorescence intensities of Zn-2BPs reached their
maximum values in an aqueous solutionwith a 50%THF volume
fraction, with more apparent emission peaks in the 500–600 nm
range than in Fig. 2, and the corresponding TEM image clearly
revealed ne spherical-shaped nanoparticles. Fig. S1† indicates
that the mean diameter of the corresponding FONs can range
from 50 nm (lower preparation concentration, 1 mM) to 560
nm (higher preparation concentration, 100 mM). Although the
sizesof thenanoparticlesweredependent on theconcentrationof
the preparation solution, the uorescence emitting wavelengths
were almost constant (Fig. 3(b)). Furthermore, the inset of
Fig. 3(b) showed that the larger size FONs can be easily prepared
and observed using uorescence microscopy. Based on the
previous studies, we inferred that the Zn-2BPs compounds could
serve as surfactant-like molecules that can further self-assemble
to form micelle-like nanoparticles due to their amphiphilic
nature11 (hydrophilic BMVC and hydrophobic porphyrin, results
for determining the critical micelle concentration and a detailed
experimental protocol are shown in Fig. S2†). Furthermore, it is
likely that the FONs formed from either packing or crowding of
the BMVC moiety, whose rotation along the molecule axis was
constrained, and then the thermal relaxation of the excited state
was decreased.13 Fig. S3† clearly shows that, based on the similar
AIEE examining protocol, BMVC oﬀered a tendency towards
FONs, but porphyrin didn’t. Hence, we proposed that the uo-
rescence intensity of BMVC will enhance when molecules aggre-
gate while the uorescence intensity of porphyrin will self-
quench when molecules aggregate with increasing concentra-
tion. That is why, in Fig. 3(b), the compound Zn-2BPs showed a
concentration-dependent nonlinear uorescence enhancement.
Consequently, a low emission BMVC monomer became a greenJ. Mater. Chem. B, 2013, 1, 2350–2357 | 2353
Fig. 3 (a) FON illustrations for 10 mMof the compound Zn-2BPs. Emission spectra
variations with aqueous solutions that contained 0, 25, 50, 75 and 100 percent-
ages of THF (Ex ¼ 470 nm). The relative visible emission photographs under UV
light (365 nm) and TEM images (scale bar: 50 nm). (b) Concentration eﬀect spectra
of FONs (50 percentages of THF aqueous solutions, Ex ¼ 470 nm) and the ﬂuo-
rescent microscopy images which were obtained from 100 mM FON solution
(excitation: 480/10 nm bp ﬁlter, emission: 510 nm lp ﬁlter, and scale bar: 1 mm).
Fig. 4 Relative DPBF oxidation rates by singlet oxygen that was generated from
the photosensitizers after irradiation with a 20 W xenon lamp. The ﬁnal output
light power was 50 mW cm2 for the 470 nm bp ﬁlter through the ﬁber. 15 mM of
the respective dyes were mixed with 500 mM of DPBF in the mixed solution (THF/
H2O ¼ 50/50, v/v), and the absorbance readings for DPBF (390 nm) were
recorded from 1 to 10 min. Each data point represents the average from three
separate experiments.
Journal of Materials Chemistry B Paperemitting uorophore under the AIEE conditions. That is why we
call BMVC the AIEE factor of the binary conjugate. The AIEE
phenomenon of the BMVCmoiety resulted from the aggregation
of Zn-2BPs, and itsuorescence enhancement was dependent on
the size of the particles but the emission wavelengths were
independent of the particles.
3 Singlet oxygen generation and intracellular accumulation
Fig. 4 presents the DPBF oxidation rates of Zn-2BPs under the
FON conditions when excited at 470 nm (THF/H2O¼ 1/1, v/v). It
is clear that the FONs formed of Zn-BPs exhibited a greater
singlet oxygen yield than this compound under the H2O and
THF conditions. In fact, the quenching of DPBF by singlet
oxygen is inhibited by H2O. Hence, based on our result, we
believe that the singlet oxygen yield of the compound in THF–
H2Omixing solution is better than in DMSO. On the other hand,
considering the deviation error bars of these data, we do not
judge that the singlet oxygen yield of Zn-2BPs is better than
2BPs under FONconditions. Though we conclude temporarily
that Zn-BPs is better than 2BPs due to a higher FRET eﬃciency,
nevertheless, in Fig. 4, we want to show that the singlet oxygen
yield of the compound in FONs formed is better than the
monomer.2354 | J. Mater. Chem. B, 2013, 1, 2350–2357As described above, Zn-2BPs is a binary compound con-
taining molecules of BMVC (green light) and metalloporphyrin
(red light); and the uorescent intensities of BMVC vary with
aggregation degrees. Hence, the evaluation of cellular uptake
requires additional investigation. At rst, the apparent uo-
rescent signals at 500–600 nm, when we collected l scanning
spectra of Zn-2BPs in HeLa cancer cells using confocal
microscopy, revealed that there were at least two sets of emis-
sion enhancements (Fig. 5(a)), which both presented more
apparent BMVC emission intensities than the spectra shown in
Fig. 3. We inferred that the unusual emission enhancement
may due to the diﬀerent degrees of FON formation of Zn-2BPs,
which resulted in the AIEE phenomena and occurred more
frequently than we expected in the HeLa cancer cells and was
observed in the spectra. Hence, when we examined the cellular
uptake of Zn-2BPs, we measured the uorescent signals using a
red lter (590 nm long pass to detect the emission for
porphyrin) and a green lter (510 nm long pass to detect the
emission for BMVC + porphyrin). It is clear that more of this
compound accumulated in the CL1-0 lung cancer cells than in
the MRC-5 normal lung cells in both cases (Fig. 5(b)). Based on
the description of Fig. 5(a), the diﬀerence in the uptake between
these two cancer cells and the MRC-5 cells was more apparent
when the signals were collected with the green lter.4 Linear and nonlinear phototoxicity
Fig. 6 reveals that no signicant dark phototoxicity was
observed for the MRC-5 normal cells aer treatment with Zn-
2BPs, whereas distinct PDT eﬀects were observed for the HeLa
cancer cells aer being irradiated with a 470 nm band pass light
source. This gure also reveals that the FRET-PDT of Zn-2BPs
was better than that of 2BPs with unapparent dark toxicity. A
similar phototoxicity result was observed when the system was
irradiated under white light (400–700 nm) as the PDT lightThis journal is ª The Royal Society of Chemistry 2013
Fig. 5 (a) Two sets of spectra representations from l scanning of confocal
microscopy images of the HeLa cancer cells. The spectra were obtained from the
average of 30 individual cancer cells. (b) Intracellular accumulation of Zn-2BPs in
MRC-5 normal and CL1-0 cancer cells. The cells were incubated with various
concentrations of the compound for 12 h, and the intracellular uptake was
determined from a ﬂuorescence calibration curve. Each data point represents the
average from three separate experiments and dashed lines indicate ﬁtting curves.
Fig. 6 Phototoxicity of HeLa cancer cells treated with Zn-2BPs (0.5, 1, 3, 5, 7, 10
and 15 mM, incubated for 12 h before irradiation) and irradiated with a 470 nm
band pass light source (30 mW cm2) for 5 min; cell death was tested overnight.
Each data point represents the average from three separate experiments and
dashed lines indicate ﬁtting curves.
Paper Journal of Materials Chemistry Bsource. Fig. 7(a) illustrates the FRET-PDT color switch process
from a real-time video recorded under a uorescence micro-
scope with a color CCD (Videos S1and S2†); it is clear that theThis journal is ª The Royal Society of Chemistry 2013cells form blebs during the late stage of irradiation and can be
easily stained with propidium iodide (Fig. S4†). Thus, we
inferred that the signicantly faster photoinduced translocation
was because the nuclear membrane was damaged during the
irradiation period and then the compound was translocated
into the nucleus, which results in a strong green emission in the
nucleus. Based on the previous studies, it is known that the
uorescence of BMVC increases by two orders of magnitude
upon interaction with DNA in the nucleus.14 The excellent
contrast during the cellular imaging of this compound can serve
as a cell death biomarker for the study of PDT.
Furthermore, BMVC has a large cross-section for two-photon
absorption at approximately 860–920 nm,15 which is a wave-
length range that is close to the optimal wavelength required for
penetrating the tissue to excite the photosensitizer. Thus,
during a nonlinear PDT test, the real-time video in Fig. 7(b),
which was collected using a 900 nm picosecond Ti-sapphire
laser beam as the light source, presented a similar result as
Fig. 7(a) and similar photo-toxicity as Fig. 6. These real time two-
photon images clearly showed that the signals of BMVC dis-
appeared in the cytoplasm but appeared in the nucleus with
irradiation. That is, we provided an additional PDT light
window in the 450–500 nm and 800–900 nm ranges, which is
absent in porphyrin and generates eﬃcient PDT without
appreciable side eﬀects in MRC-5 normal cells. Here, we must
claim that (1) we want to emphasize that photo-induced cell
death accompanied by color-change or photo-induced trans-
location phenomena, color CCD with a long-pass lter is
necessary. (2) This phenomenon of this compound happens too
fast under the laser sources (405 or 488 nm laser), and it is hard
to collect the video results in Fig. 7(a) under a confocal system
(that is why we presented videos). (3) In the two-photon system,
photo-induced color change became slower and we can collect
the video between the PDT periods with a self-fabricated Ti-
sapphire laser collocating a mono-color CCD (pseudo-color in
Fig. 7(b)). (4) The double-staining protocol is unsuitable in
performing Fig. 7, because the staining of nuclear probes
(Hoechst or PI) will interrupt the color presentation, that is why
we present the bright-eld image.5 Sub-cellular localization
We have explained that why uorescence microscopy
measurement is more suitable than confocal measurement in
our case. For a binary compound which contains a green
emission BMVC and a red emission metalloporphyrin, its
intracellular uorescent signals vary during irradiation. The
sub-cellular localization of this compound is diﬃcult to carry
out. Furthermore, the green and red lters captured the uo-
rescence from the tracker green and metalloporphyrin portion
of Zn-2BPs, respectively. Primarily, the red lter exposure time
was approximately 3–4 times longer than the green lter and
then it was possible to enhance the FRET image signal for the
metalloporphyrin whose emission overlapped with the tracker
red uorescence. That is why dual staining was not successful
for these conjugates using MitoTracker Red or LysoTracker Red.
Hence, to determine the localization of each compound, asJ. Mater. Chem. B, 2013, 1, 2350–2357 | 2355
Fig. 7 (a) Several selected ﬂuorescent and bright-ﬁeld images from a real-time video (Videos S1 and S2†) for photo-induced translocations of a 10 mM compound
(ﬂuorescence images were excited by a blue light cube that passed light through a 480/10 nm bp ﬁlter, and the emission was collected through a 510 nm lp ﬁlter of a
ﬂuorescent microscope). (b) Experiment similar to that presented in (a) but with the use of a Ti-sapphire laser at a wavelength of 900 nm as the light source (Video S3†).
In the image/video the ﬂuorescence was pseudo-colored in yellow from a mono-color CCD.
Journal of Materials Chemistry B Paperdetailed in the Experimental section, the cell incubated with
compound Zn-2BPs was double stained with the cellular tracker
green, which merged with the red light emission region of Zn-
2BPs. Fig. 8 reveals that Zn-2BPs may be localized predomi-
nantly in mitochondria and lysosome. Generally, mitochondrial
photodamage has been reported to be the primary cause of
apoptosis during PDT because mitochondria play an integral
role in various cell biological processes, such as energy
production, apoptotic cell death, molecular metabolism,
calcium signaling, and cell redox status.16,17 However, lysosomal
photodamage has also been reported to induce apoptosis in
PDT, although this sub-cellular localization has been attributed
to either the relocalization of the photosensitizers to mito-
chondria or the destabilization of the photosensitizers aer the
PDT process.16,18 Consequently, mitochondria and lysosomesFig. 8 Sub-cellular localization of Zn-BPs in HeLa cancer cells from ﬂuorescent
microscopy. The images of the green tracker were excited by a blue light cube that
passed light through a 480/10 nm bp ﬁlter, and the emission was collected
through a 510 nm lp ﬁlter. The red images of the compound were excited by a
green light cube that passed light through a 530/20 nm bp ﬁlter, and the emis-
sion was collected through a 590 nm lp ﬁlter.
2356 | J. Mater. Chem. B, 2013, 1, 2350–2357are very attractive sites for the localization of the photosensi-
tizers to improve the eﬃciency of the PDT. Indeed, we have
double-stained this compound with other probes and only
mitotracker and lysotracker found the possible co-localization
merge images.
It is interesting that the PDT eﬀects of 2BPs and Zn-2BPs are
better than what we expected. Hence, we try to analyze the
phototoxicity eﬃciency and possible mechanism of Zn-2BPs. In
a previous study we investigated that the extra phototoxic eﬀect
of 2BPs could result from a photo-induced reaction of BMVC in
addition to its dark toxicity.11 Recently, we found that light-
induced photo-reduction of BMVC generated an apparent
increase in the signal from the free radical probe 4-((9-acridi-
necarbonyl) amino)-2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO-
9-ac, Invitrogen, Carlsbad, CA), as the most PDT type I cases.19
Meanwhile, PDT protocols showed that BMVC-PDT treatment
signicantly inhibited the growth of tumor cells both in the
in vitro and in vivo studies. Eventually, we have successfully
applied BMVC for tumor targeting markers and treatment and
demonstrated that BMVC may be a potent tumor-specic
photosensitizer for PDT.20 That is why the PDT eﬃciency of the
BMVC–porphyrin binary conjugate is much better than
porphyrin and additionally, Zn-2BPs is better than 2BPs with
more eﬀective FRET eﬀect.Conclusion
In summary, the Zn-2BPs compound was designed to oﬀer
better FRET eﬃciency between BMVC and metalloporphyrin.
The key function is that the Zn-2BPs can self-assemble to form
FONs that result in AIEE in vitro and in the cells. Consequently,
the FRET occurred from the aggregated BMVC to theThis journal is ª The Royal Society of Chemistry 2013
Paper Journal of Materials Chemistry Bmetalloporphyrin and generated additional singlet oxygen for
eﬃcient PDT. Therefore, the PDT characteristics of the Zn-2BPs
compound include (1) both target and irradiation wavelength
selectivity for the PDT of HeLa and CL1-0 cancer cells; (2)
excellent contrast during cellular imaging, which can be applied
to monitor the pathway of PDT and serve as a cell death marker;
(3) similar PDT behavior under linear and nonlinear (two
photon emission) light sources; (4) diminished the aggregation-
induced PDT disadvantage; and (5) BMVC supported extra
phototoxicity.
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